Back to search

National and Kapodistrian University of Athens

Συσχέτιση in vivo απαντήσεων και κλινικού φαινοτύπου ασθενών με αντιδράσεις υπερευαισθησίας φαρμακολογικής αιτιολογίας

Abstract

dc:description

Introduction: Drug Ηypersensitivity reactions(DHRs) although occur extremely often,seldom undergo full allergological evaluation and diagnostic testing. Epidemiological data ondrug hypersensitivity in Greece, documented by specialists, is not available up to date.Aim: the primary goal is to record DHRs in a tertiary hospital allergy unit while additionalsecondary goals are the identification of possible risk factors for DHRs, the comparativeevaluation of drug allergy phenotypes (single vs multiple reactors) and the detection ofpossible correlations between the recorded parameters.Methods: All patients that referred to Allergy Unit “D.C Kalogeromitros” during a three-yearperiod, for “drug allergy”, were evaluated as follows: record of standardized drug allergyhistory, in vivo skin testing, in vitro measurement of specific ΙgEs (b lactams) , and drugprovocation tests (DPTs) at the offending or alternative drug according to the guidelines.Values are expressed as mean ±SD.Results: 1130 patients (mean age 45.9±17.9 years) with 824 (72,9%) females, were includedin study analysis. Almost 40% reported as single reactors while 60% stated reactions to morethan one drug classes. The reaction occurred at the 8.6 ±73.5 day of treatment, while in caseof acute DHRs, the mean time until the onset of symptoms was 23.5± 18.5 minutes.Immediate DHRs were reported in 35.6%, non-immediate in 50.9% while 13.5% did notremember the time of symptoms’ onset. The prevalent clinical manifestations werε:urticaria/angioedema 42.1%, anaphylaxis 19.1% and maculopapular exanthema 16.8%. Themost common drug classes involved in DHRs were b-lactams (45.6%) and NSAIDs (13%)while the prevalent molecules were amoxicillin 13.7% and amoxicillin-clabulanic acid 10.4%.Skin testing was not performed as not-necessary in 54.2% and was positive in 23.8% of thosethat underwent tests. Specific serum IgEs were positive in 11.2%. Atopy was documented in21.6% while if atopic history was added, atopy was present in almost 30%. Personal historyof chronic urticaria was reported in 17% while familiar history of drug allergy was recordedin 13.4%. DPTs to the offending drug were negative in 94.7% (178/188) while almost allperformed DPTs in alternative drug (155/159, 99.6%) were also negative.Conclusions: Full allergological evaluation of DHRs drives to totally different definitiveconclusions compared to the patients’ or doctors’ perception on drug allergy. The DPTs whenperformed according to guidelines are safe and represent the gold standard of the diagnosticprocedures in drug allergy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Polyzoy, Efthimia
  • Πολύζου, Ευθυμία

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41919

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Polyzoy, Efthimia; Πολύζου, Ευθυμία. Συσχέτιση in vivo απαντήσεων και κλινικού φαινοτύπου ασθενών με αντιδράσεις υπερευαισθησίας φαρμακολογικής αιτιολογίας. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/41919